Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Good
|
Filing tables
Filing exhibits
Related press release
Associated OMIC transcripts
OMIC similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statement (Form S-8 Nos. 333-256568 & 333-259064) pertaining to the Singular Genomics Systems, Inc. 2021 Equity Incentive Plan, the Singular Genomics Systems, Inc. 2021 Employee Stock Purchase Plan and the Singular Genomics Systems, Inc. 2016 Stock Plan of Singular Genomics Systems, Inc. of our report dated March 14, 2022, with respect to the financial statements of Singular Genomics Systems, Inc., included in this Annual Report (Form 10-K) for the year ended December 31, 2021.
/s/ Ernst & Young LLP
San Diego, California
March 14, 2022